Replies to post #19133 on Revive Therapeutics Ltd (RVVTF)

[Ecomike]

Thanks, I think it was your earlier $RVVTF post I found the PDF on.

This looks like the most promising upside #Biotech #Covid19 drug trial stock I know of right of right now.

I found this stock earlier in an email link to a seeking alpha article, sent it to one of my buddies, Drugman... and he got in and reminded me later to look at it again. Then I researched the Bucillaime and RA applications (I have RA...and I have bio-chemical Engineering back ground/degrees... so I know one hell of lot about it and the biochemistry and drugs..)

But I had not seen that pdf, so I may be loading a few boats this week before we make new 2020 highs.

This actually could go to $10/share if what I read in that paper pans out in Covid19 trials. If not, it is still about to be a $2 to $3 stock just based on the reduced Cytokine storm life laving potential.

But if it can stop serious infections by cripple the virus's ability to infect cells, I do not think the bulk of the medical Biotech community even has this on their radar yet.